Pillar 2: Translating Research into Applications That Solve Problems
With a sophisticated framework and in-depth expertise, CBI is poised to pursue groundbreaking translational research, tailoring its tools and methods to enable innovative approaches to preventing, diagnosing and treating disease and adapting to the growing threat of climate and ecosystem change, among other major challenges facing humanity. In fact, CBI has already pioneered methods to trace disease outbreaks, study the evolution of drug resistance and diagnose the root cause of illnesses faster and more effectively. CBI faculty also helped develop Galaxy, an open-source platform that makes it easier for scientists and physicians to perform analyses, as well as reproduce and share genomic information for cancer and other biomedical research. In addition, CBI identified genetic indicators of stress and recovery in crustaceans that helped uncover and monitor the true impact of the Deepwater Horizon oil spill on the other important species in the Gulf of Mexico. Research partnerships with human health-based organizations like the NIH-funded DC Children’s National Medical Center are set to make advances in the study of evolution of diseases and drug resistance and personalized medicine based on individual genetics and biomarkers. In addition, CBI takes advantage of its proximity to organizations such as the U.S. Fish and Wildlife Service, the U.S. Food and Drug Administration and the Smithsonian Institution, by partnering with them to help protect important plants and animals that our communities rely on for food and healthy, life-sustaining ecosystems.